logo
Canada faces pain medicine shortage and here's what can you do

Canada faces pain medicine shortage and here's what can you do

Time of India25-07-2025
Canada is grappling with a nationwide shortage of prescription pain medications containing acetaminophen with codeine or oxycodone, impacting drugs like Percocet and Tylenol No. 3. Manufacturing disruptions and increased demand are the primary causes. Pharmacists are dispensing limited quantities, and the shortage is expected to last until early August 2025, with a significant resupply anticipated.
Canada faces a national shortage of key pain medications like Percocet and Tylenol 3, affecting patients across the country. Health Canada cites supply disruptions and rising demand, with relief expected by early August 2025.
Tired of too many ads?
Remove Ads
Pharmacists say limited supply
Tired of too many ads?
Remove Ads
When will supply resume?
Health Canada warning
FAQs
What pain medications are currently in short supply in Canada?
How long will the prescription drug shortage in Canada last?
Tired of too many ads?
Remove Ads
What should I do if my prescribed pain medication is unavailable?
Canada is currently experiencing a nationwide shortage of some commonly used prescription pain medications . Health Canada issued a notice on July 18 confirming that drugs containing acetaminophen with codeine or oxycodone are in limited supply. These medications are often used to manage moderate to severe pain.Products affected include combinations of acetaminophen with oxycodone (sold under brand names like Percocet) and acetaminophen with codeine (such as Tylenol No. 3). Other impacted formulations include Teva-Oxycocet, Teva-Lenoltec No. 1 to 4, and Rivacocet.Pharmaceutical companies such as Teva Canada Ltd. , Laboratoire Riva Inc. , and Pharmascience Inc. have cited manufacturing disruptions and increased demand as reasons for the shortage.To manage the shortage, pharmacists across the country have been dispensing limited quantities. Sadaf Faisal, senior director of professional affairs at the Canadian Pharmacists Association (CPA), told Global News that pharmacists currently supply only a 30-day supply in some cases due to low availability.Some pharmacists are also reaching out to other pharmacies to source additional stock.The CPA expects the shortage to last until early August, with a significant resupply anticipated at that time. In the meantime, Health Canada urges patients to speak with their doctors or pharmacists if they are affected.Alternative pain relief options may be available, but any change in medication requires physician approval due to federal drug regulations.Canadians are advised to use only licensed pharmacies and avoid unverified online sellers.Health Canada warns that unregulated sources may sell products lacking active ingredients or containing dangerous substances.Canada is facing a shortage of prescription drugs containing acetaminophen with codeine or oxycodone, including Percocet, Tylenol No. 3, Teva-Oxycocet, and Rivacocet. These are commonly used for pain relief.According to the Canadian Pharmacists Association (CPA), the shortage is expected to continue until early August 2025, when a significant resupply is anticipated.Patients should consult their doctor or pharmacist for safe and effective alternatives. Due to Canadian regulations, pharmacists need physician approval before changing or substituting any controlled medications.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Robotic surgery facility makes debut at AIMSS Chamiyana
Robotic surgery facility makes debut at AIMSS Chamiyana

Time of India

timea day ago

  • Time of India

Robotic surgery facility makes debut at AIMSS Chamiyana

Shimla: Chief minister Sukhvinder Singh Sukhu on Monday inaugurated the state's first robotic surgery facility and witnessed the first operation performed using this advanced technology at the Atal Institute of Medical Super Specialties , Chamiyana in Shimla. He reviewed the hospital's functioning in a meeting with staff and assured full govt support for strengthening the institute. He announced the creation of new departments, recruitment of lab technicians and dialysis technicians, and allocation of Rs 11 crore for the construction of a hostel. A high-end 3-Tesla MRI machine will also be installed soon, he added. Sukhu announced Rs 23 crore for setting up an in-house automated lab at Chamiyana. Sukhu said the govt is investing over Rs 3,000 crore in modern healthcare technology, replacing outdated machines, including the 20-year-old MRI machine at IGMC Shimla. A resident of Khalini in Shimla, suffering from a prostate-related ailment, became the first patient to undergo robotic surgery in the state.

Robotic surgery facility makes debut in Himachal
Robotic surgery facility makes debut in Himachal

Time of India

time3 days ago

  • Time of India

Robotic surgery facility makes debut in Himachal

Shimla: Chief minister Sukhvinder Singh Sukhu on Monday inaugurated the state's first robotic surgery facility and witnessed the first operation performed using this advanced technology at the Atal Institute of Medical Super Specialties, Chamiyana in Shimla. Sukhu also reviewed the hospital's functioning in a meeting with staff and assured full govt support for strengthening the institute. He announced the creation of new departments, recruitment of lab technicians and dialysis technicians, and allocation of Rs 11 crore for the construction of a hostel. A high-end 3-Tesla MRI machine will also be installed soon, he added. Sukhu also announced Rs 23 crore for setting up an in-house automated laboratory at Chamiyana. Recalling his own robotic surgery five years ago, Sukhu said that this was the seed of an idea, and on Monday, it became a reality at AIMSS Chamiyana. With this facility, cutting-edge medical care will now be accessible even to common people. Soon, robotic surgery services will be introduced in a phased manner in the IGMC Shimla and other medical colleges at Nerchowk, Tanda, and Hamirpur. Sukhu said the govt is investing over Rs 3,000 crore in modern healthcare technology, replacing outdated machines, including the 20-year-old MRI machine at the IGMC Shimla. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Become Fluent in Any Language Talkpal AI Undo He stressed that health sector reforms remain a top priority, with no shortage of funds. First patient A resident of Khalini in district Shimla, suffering from a prostate-related ailment, became the first patient to undergo robotic surgery in the state. A team comprising Dr Anant Kumar, Dr Pamposh Raina, and Dr Pawan Kaundal successfully performed the first robotic surgery. According to the doctors, the procedure went for almost three hours, whereas in routine surgery, it could have taken at least five hours. There was no blood loss of the patient during the operation, but the conventional procedure would have required four units of blood. According to them, the patient is expected to be discharged from the hospital within 3-4 days compared to the 8-10 days requirement in a traditional operation. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.

Zydus receives NOC from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg
Zydus receives NOC from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg

Business Standard

time7 days ago

  • Business Standard

Zydus receives NOC from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg

Zydus Lifesciences (including its subsidiaries/ affiliates, hereafter referred to as Zydus) has received NOC (Notice of Compliance) from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg. This is the group's first NOC approval in Canada. Varenicline is used as an aid in smoking cessation. It is a partial nicotinic acetylcholine receptor agonist, designed to partially activate this system while displacing nicotine at its sites of action in the brain. ZDS-Varenicline tablets will be produced at Zydus Lifescience, SEZ, Ahmedabad. Varenicline tablets had annual sales of 15 mn Canadian dollar in Canada (IQVIA MAT December 2024).

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store